Safety and Efficacy of HMI-103 in Participants With Classical PKU Due to PAH Deficiency
Clinical trial NCT05222178 · TERMINATED
Trial details
- NCT number
- NCT05222178
- Sponsor
- Homology Medicines, Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-03
- Primary completion
- 2023-09-14
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.